Skip to Content
Skip to Content

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 26 November 2020. Database contains 260 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
225-863-2
5124-30-1
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
Bisphenol A; BPA
201-245-8
80-05-7
Germany
Aggregated tonnage
Endocrine disruption
Widespread use
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
223-861-6
4098-71-9
Germany
Carcinogenic
Exposure
Mutagenic
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
202-112-7
91-97-4
Germany
Mutagenic
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-039-0
91-08-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
219-470-5
2440-22-4
Germany
Other human toxicity
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
603-051-2
125304-04-3
Germany
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
01/04/2015
Details
253-037-1
36437-37-3
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
274-570-6
70321-86-7
Germany
Endocrine disruption
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
422-600-5
-
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
223-383-8
3864-99-1
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
219-799-4
2536-05-2
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
3-benzylidene camphor; 3-BC
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
221-641-4
3173-72-6
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
204-661-8
123-91-1
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
23/06/2020
Details
211-463-5
646-06-0
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
220-474-4
2778-42-9
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
701-028-2
-
France
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Other
24/05/2019
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
11/09/2019
Details
202-924-1
101-20-2
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
201-067-0
77-90-7
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/11/2016
Details
201-071-2
77-94-1
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
22/01/2019
Details
260-830-6
57583-54-7
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
246-563-8
25013-16-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Restriction
17/01/2019
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/03/2017
Details
-
-
France
Carcinogenic
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
28/01/2020
Details
201-581-5
85-01-8
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/10/2017
Details
205-391-3
140-01-2
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
01/04/2016
Details
247-421-8
26038-87-9
France
Endocrine disruption
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
232-104-9
7786-81-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
02/02/2017
Details
234-323-5
11099-02-8
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
02/02/2017
Details
236-068-5
13138-45-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
235-008-5
12054-48-7
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
231-743-0
7718-54-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
242-522-3
18718-11-1
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
200-652-8
67-43-6
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
01/04/2016
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
03/05/2019
Details
200-001-8
50-00-0
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
231-892-1
7775-27-1
France
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
Other legislation
09/03/2020
Details
231-781-8
7727-21-1
France
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other legislation
12/03/2020
Details
231-786-5
7727-54-0
France
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other legislation
09/03/2020
Details
229-176-9
6422-86-2
France
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
25/01/2019
Details
201-469-6
83-32-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
11/12/2015
Details
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
Bisphenol A; BPA
201-245-8
80-05-7
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details

Export search results to:

Categories Display


Route: .live2